IsoPlexis Corp. UK Ltd

Silver Sponsor

IsoPlexis, a privately held life sciences company, is developing novel technologies at the forefront of cell therapy and immune-based treatments of cancer. Using our secreted proteomic platform to identify patient responses at the single cell level, IsoPlexis' original scientific leaders from Yale, Caltech, UCLA, and Memorial Sloan Kettering Cancer Center are advancing the understanding of personalized therapies against cancer.


Festibval of Biologics


There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.